Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.

The major purpose of this exploratory developmental study will be to develop a patient-centered and feasible protocol for communicating genetic data as it relates to drug efficacy for smoking cessation inpatients receiving medication that is matched to individual genotypes associated with increased efficacy for bupropion or nicotine replacement therapy.

Principal Investigator

CONTACT INFORMATION

Primary Contact:
Sean David
(650) 498-4687